L3HYPDH (trans-L-3-hydroxyproline dehydratase) can be functionally activated through various biochemical mechanisms, primarily involving phosphorylation events that alter its activity. Specific activators exert their influence through modulation of intracellular signaling pathways, leading to enhanced phosphorylation and resultant activity of L3HYPDH. For instance, activation of adenylyl cyclase leads to an increase in cyclic AMP (cAMP) levels, which is known to activate protein kinase A (PKA). Once activated, PKA can phosphorylate target proteins, including L3HYPDH, thereby enhancing its enzymatic function. Similarly, activation of protein kinase C (PKC) through certain activators results in phosphorylation events that may include L3HYPDH as a target. PKC activation is commonly triggered by diacylglycerol analogs and can lead to phosphorylation of various proteins, potentially influencing L3HYPDH activity as well. Furthermore, elevations in intracellular calcium levels can activate calcium-dependent protein kinases, which are capable of phosphorylating a range of substrates, potentially including L3HYPDH, thereby modulating its activity.
Apart from phosphorylation, L3HYPDH activity can be indirectly influenced by alterations in other signaling pathways that affect its expression levels or the activation of related proteins. For example, the PI3K/AKT signaling pathway, which can be modulated by insulin, plays a critical role in a multitude of cellular processes, including protein phosphorylation. Alterations in this pathway could lead to enhanced L3HYPDH activation through potential downstream phosphorylation events. Additionally, the JNK/SAPK pathway, which responds to various stress stimuli, can activate transcription factors that may augment L3HYPDH expression and activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which could phosphorylate L3HYPDH or associated proteins, resulting in enhanced L3HYPDH activity. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Increases intracellular calcium concentration, which may activate calcium-dependent protein kinases that phosphorylate L3HYPDH, thereby increasing its activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic receptor agonist which increases intracellular levels of cAMP, potentially leading to activation of PKA and subsequent phosphorylation and activation of L3HYPDH. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Activates the PI3K/AKT signaling pathway which can lead to the phosphorylation and activation of proteins, including L3HYPDH. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Stimulates adenylyl cyclase through G-protein coupled receptors, increasing cAMP levels and potentially leading to PKA-mediated L3HYPDH activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, leading to increased cAMP levels which could enhance PKA activity and subsequently L3HYPDH activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that activates PKA, which could then phosphorylate and activate L3HYPDH. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that permeates cell membranes and activates PKA, which can lead to increased L3HYPDH activity through phosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activator of the JNK/SAPK signaling pathway, which could lead to the activation of transcription factors that elevate L3HYPDH expression and activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibitor of PI3K, leading to alterations in downstream signaling pathways which may indirectly upregulate and activate L3HYPDH through compensatory mechanisms. | ||||||